XOMA Royalty Corporation (XOMA)
NASDAQ: XOMA · Real-Time Price · USD
26.38
-0.48 (-1.79%)
At close: Mar 13, 2026, 4:00 PM EDT
27.00
+0.62 (2.35%)
After-hours: Mar 13, 2026, 7:18 PM EDT
XOMA Royalty Employees
XOMA Royalty had 13 employees as of December 31, 2024. The number of employees did not change compared to the previous year.
Employees
13
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
$3,623,538
Profits / Employee
$758,154
Market Cap
313.62M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2024 | 13 | 0 | - | 13 | 0 |
| Dec 31, 2023 | 13 | 0 | - | 13 | 0 |
| Dec 31, 2022 | 13 | 1 | 8.33% | 12 | 1 |
| Dec 31, 2021 | 12 | 2 | 20.00% | 12 | 0 |
| Dec 31, 2020 | 10 | 0 | - | 10 | 0 |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Puma Biotechnology | 179 |
| Cabaletta Bio | 151 |
| Prelude Therapeutics | 131 |
| Nautilus Biotechnology | 130 |
| Adlai Nortye | 123 |
| Silence Therapeutics | 116 |
| Foghorn Therapeutics | 112 |
| Rezolute | 75 |
XOMA News
- 1 day ago - XOMA Royalty to Report Fourth Quarter and Full Year 2025 Financial Results on March 18, 2026 - GlobeNewsWire
- 4 weeks ago - XOMA Royalty: Preferreds Still Offer Compelling Income Despite Call Risk - Seeking Alpha
- 4 weeks ago - XOMA Royalty Announces Closing of Tender Offer and Completed Acquisition of Generation Bio, Inc. - GlobeNewsWire
- 2 months ago - XOMA Royalty Announces CFO Transition - GlobeNewsWire
- 2 months ago - XOMA Royalty Declares Quarterly Preferred Stock Dividends - GlobeNewsWire
- 3 months ago - XOMA Royalty Announces Closing of Transaction to Acquire Mural Oncology plc - GlobeNewsWire
- 3 months ago - Mural Oncology Announces Sanction of the Scheme by the High Court - GlobeNewsWire
- 4 months ago - XOMA Royalty Announces Closing of Transactions to Acquire LAVA Therapeutics N.V. - GlobeNewsWire